DalsnaFinance

GSK boosts cancer portfolio with $10.6 billion Nuvalent takeover

Markets Reuters By Reuters 09 Jun 2026 06:04 1 min read
GSK boosts cancer portfolio with $10.6 billion Nuvalent takeover

GSK boosts cancer portfolio with $10.6 billion Nuvalent takeover  Reuters

GSK boosts cancer portfolio with $10.6 billion Nuvalent takeover Reuters

Read the full story on Reuters → Opens the original article on news.google.com

Summary aggregated from Reuters's public RSS feed. The full reporting belongs to Reuters — please read it on their site.